Q4 2025 · 13F-HR
Knoll Capital Management, LLCholdings as filed
Filed 2026-02-17 · accession 0001104659-26-016376
$218.0M
Reported value
33
Positions
2025-12-31
Period end
The Brief · Knoll Capital Management, LLC · Q4 2025
AI · grounded in 13F
Knoll Capital Management, LLC closed its position in Sandstorm Gold Ltd AYS1, reducing exposure by $8.76M. The fund established a new position in SSR Mining Inc SSRM valued at $5.37M. Other notable activity includes increasing share counts in Royal Gold Inc. RGLD by 486.11% and Abeona Therapeutics ABEO by 276.39%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 01438T106 | ALDX | Aldeyra Therapeutics Inc | $28.4M | 13.0% | 5,475,516 | Common | SOLE |
| G11196105 | — | Biohaven Pharmactl Hldg Co L | $26.3M | 12.1% | 2,328,602 | Common | SOLE |
| 67080N101 | NUVB | Nuvation Bio Inc | $13.4M | 6.16% | 1,498,591 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals Plc | $12.9M | 5.93% | 600,000 | Common | SOLE |
| 78463V107 | GLD | SPDR Gold Trust | $12.7M | 5.82% | 32,000 | Common | SOLE |
| 780287108 | RGLD | Royal Gold Inc. | $11.7M | 5.38% | 52,750 | Common | SOLE |
| 496902404 | KGC | Kinross Gold Corp | $11.5M | 5.30% | 410,000 | Common | SOLE |
| M40527109 | ENTX | Entera Bio Ltd | $11.4M | 5.23% | 5,881,879 | Common | SOLE |
| G59665102 | MGTX | MeiraGTX Holdings | $9.9M | 4.56% | 1,250,000 | Common | SOLE |
| 811916105 | SA | SEABRIDGE GOLD INC | $9.4M | 4.30% | 317,003 | Common | SOLE |
| 008474108 | AEM | Agnico Eagle Mines Ltd | $8.9M | 4.10% | 52,750 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix Inc. | $7.3M | 3.34% | 600,400 | Common | SOLE |
| 152006102 | CGAU | Centerra Gold Inc | $7.1M | 3.28% | 497,402 | Common | SOLE |
| 784730103 | SSRM | SSR Mining Inc | $5.4M | 2.46% | 245,000 | Common | SOLE |
| 697900108 | PAAS | Pan American Silver | $5.2M | 2.38% | 100,035 | Common | SOLE |
| 351858105 | FNV | Franco Nev Corp | $5.2M | 2.38% | 25,000 | Common | SOLE |
| 46428Q109 | SLV | iShares Silver Trust | $5.2M | 2.36% | 80,000 | Common | SOLE |
| 28657F103 | ELTX | Elicio Therapeutics Inc | $5.0M | 2.30% | 630,915 | Common | SOLE |
| 02155H200 | ALT | Altimmune Inc | $4.0M | 1.86% | 1,121,524 | Common | SOLE |
| 89679M104 | TFPM | Triple Flag Precious Metals | $2.0M | 0.90% | 58,800 | Common | SOLE |
| 011532108 | AGI | Alamos Gold Inc | $1.9M | 0.88% | 50,000 | Common | SOLE |
| 192108504 | CDE | Coeur Mining Inc | $1.7M | 0.79% | 96,132 | Common | SOLE |
| 64782A107 | NEWP | New Pac Metals Corp | $1.7M | 0.78% | 485,000 | Common | SOLE |
| 464288760 | ITA | iSHares US Aerospace & Defense | $1.6M | 0.75% | 7,650 | Common | SOLE |
| 718172109 | PM | Philip Morris Intl. Inc | $1.6M | 0.74% | 10,000 | Common | SOLE |
| 962879102 | WPM | Wheaton Precious Metals Corp | $1.5M | 0.67% | 12,500 | Common | SOLE |
| 00289Y206 | ABEO | Abeona Therapeutics | $1.2M | 0.57% | 235,953 | Common | SOLE |
| 666807102 | NOC | Northrop Grumman Corp | $1.2M | 0.57% | 2,165 | Common | SOLE |
| 099502106 | BAH | Booz Allen Hamilton HLDG COR | $1.1M | 0.50% | 13,000 | Common | SOLE |
| 46655E100 | DC | Dakota Gold Corp | $698,191 | 0.32% | 122,921 | Common | SOLE |
| 03828A101 | APLT | Applied Therapeutics Inc | $605,000 | 0.28% | 6,050,000 | Common | SOLE |
| 14161Y200 | CRDL | Cardiol Therapeutics Inc | $95,300 | 0.04% | 100,000 | Common | SOLE |
| 68619K105 | — | Orgenesis, Inc. | $7,593 | 0.00% | 50,623 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.